Gastroenterology
Volume 137, Issue 5 , Pages 1795-1804, November 2009

Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice

  • Charis L. Johnson

      Affiliations

    • Children's Health Research Institute, London, Ontario
    • Department of Paediatrics, The University of Western Ontario, London, Ontario
    • ,
  • Jacqueline Y. Weston

      Affiliations

    • Children's Health Research Institute, London, Ontario
    • Department of Physiology & Pharmacology, The University of Western Ontario, London, Ontario
    • Department of Paediatrics, The University of Western Ontario, London, Ontario
    • ,
  • Sami A. Chadi

      Affiliations

    • Children's Health Research Institute, London, Ontario
    • Department of Paediatrics, The University of Western Ontario, London, Ontario
    • ,
  • Elena N. Fazio

      Affiliations

    • Children's Health Research Institute, London, Ontario
    • Department of Physiology & Pharmacology, The University of Western Ontario, London, Ontario
    • Department of Paediatrics, The University of Western Ontario, London, Ontario
    • ,
  • Murray W. Huff

      Affiliations

    • Department of Biochemistry, The University of Western Ontario, London, Ontario
    • ,
  • Alexei Kharitonenkov

      Affiliations

    • Lilly Research Laboratories, Division of Eli Lilly, Indianapolis, Indiana
    • ,
  • Anja Köester

      Affiliations

    • Lilly Research Laboratories, Division of Eli Lilly, Indianapolis, Indiana
    • ,
  • Christopher L. Pin

      Affiliations

    • Children's Health Research Institute, London, Ontario
    • Department of Physiology & Pharmacology, The University of Western Ontario, London, Ontario
    • Department of Paediatrics, The University of Western Ontario, London, Ontario
    • Corresponding Author InformationReprint requests Address requests for reprints to: Christopher Pin, PhD, Department of Paediatrics, The University of Western Ontario, Children's Health Research Institute, 5th Floor, Victoria Research Laboratories, London, Ontario, Canada, N6C 2V5. fax: (519) 685-8186

Received 22 July 2008; accepted 30 July 2009. published online 07 August 2009.

Background & Aims

Fibroblast growth factor 21 (FGF21) acts as a hormonal regulator during fasting and is involved in lipid metabolism. Fgf21 gene expression is regulated by peroxisome proliferator-activated receptor (PPAR)-dependent pathways, which are enhanced during pancreatitis. Therefore, the aim of this study was to investigate FGF21's role in pancreatic injury.

Methods

Fgf21 expression was quantified during cerulein-induced pancreatitis (CIP) or following mechanical or thapsigargin-induced stress through Northern blot analysis, in situ hybridization, and quantitative reverse transcription polymerase chain reaction. FGF21 protein was quantified by Western blot analysis. Isolated acinar cells or AR42J acinar cells were treated with recombinant FGF21 protein, and extracellular regulated kinase 1/2 activation was examined. The severity of CIP was compared between wild-type mice and mice overexpressing FGF21 (FGF21Tg) or harboring a targeted deletion of Fgf21 (Fgf21−/−).

Results

Acinar cell Fgf21 expression markedly increased during CIP and following injury in vitro. Purified FGF21 activated the extracellular regulated kinase 1/2 pathway in pancreatic acinar cells. The severity of CIP is inversely correlated to FGF21 expression because FGF21Tg mice exhibited decreased serum amylase and decreased pancreatic stellate cell activation, whereas Fgf21−/− mice had increased serum amylase and tissue damage. The expression of Fgf21 was also inversely correlated to expression of Early growth response 1, a proinflammatory and profibrotic transcription factor.

Conclusions

These studies suggest a novel function for Fgf21 as an immediate response gene protecting pancreatic acini from overt damage.

Abbreviations used in this paper: CCK, cholecystokinin, CIP, cerulein-induced pancreatitis, CPA, carboxypeptidase, PDGF, platelet-derived growth factor, EGR-1, Early growth response 1, ERK1/2, extracellular regulated kinase 1/2, IL-6, interleukin 6, JNK, Jun N-terminal kinase, PPAR, peroxisome proliferator-activated receptor, PSC, pancreatic stellate cells, SMA, smooth muscle actin, WT, wild type

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by operating grants from the Canadian Institutes of Health Research (CIHR; CP-MOP 53083), Children's Health Research Institute, and Lawson Health Research Institute; by an Ontario Graduate Scholarship for Science and Technology (to J.W.); and by a New Investigator Award from the CIHR (to C.P.).

PII: S0016-5085(09)01389-4

doi:10.1053/j.gastro.2009.07.064

Refers to article:

  • A Novel Role for the Fibroblast Growth Factor 21 in Acute Pancreatitis , 01 October 2009

    Hana Algül
    Gastroenterology November 2009 (Vol. 137, Issue 5, Pages 1577-1579)

Gastroenterology
Volume 137, Issue 5 , Pages 1795-1804, November 2009

Article Tools

* Image Usage & Resolution